Contribution of FDG-PET/CT to the management of esophageal cancer patients at multidisciplinary tumor board conferences

by Kumar K. Shashi, Rachna Madan, Mark M. Hammer, Steven van Hedent, Suzanne C. Byrne, Eric J. Schmidlin, Harvey Mamon, Hiroto Hatabu, Peter C. Enzinger, Victor H. Gerbaudo
Published 2020-01-01

Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer.

by Jeffrey A Meyerhardt, Marek Ancukiewicz, Thomas A Abrams, Deborah Schrag, Peter C Enzinger, Jennifer A Chan, Matthew H Kulke, Brian M Wolpin, Michael Goldstein, Lawrence Blaszkowsky, Andrew X Zhu, Meaghan Elliott, Eileen Regan, Rakesh K Jain, Dan G Duda
Published 2012-01-01